منتديات - منتدى - شدات ببجي - شحن شدات ببجي - شحن ببجي - متجر ببجي - متجر شدات ببجي - شعبية ببجي - شدات - شحن روبلوكس - شحن يلا لودو - اقساط - شدات ببجي اقساط - شدات ببجي - شدات ببجي تمارا - شدات ببجي تابي - شحن يلا لودو - شحن يلا لودو اقساط - تقسيط بطاقات سوا - موبايلي اقساط - زين اقساط - ايتونز امريكي اقساط - ايتونز سعودي اقساط - شعبية ببجيمتجر اقساط - شدات ببجي - حسابات ببجي - شدات ببجيشدات ببجي اقساط - شدات ببجي - متجر busd
alabdy Senior Member

In the U.S., emergency-use authorization has been granted for convalescent plasma, the efficacy of which is yet to be robustly tested. For some, this echoes the situation with hydroxychloroquine and the government’s subsequent U-turn on its rollout.

Meanwhile, America’s infection rate appears to be flattening out — but at tens of thousands of cases per day. This stands in stark contrast to China, where daily cases are under 40.

Overseas, a Hong Kong resident has been reinfected with the virus, the first recorded instance of a second bout. And Russia and China have begun distributing vaccines, sidestepping Phase 3 safety trials to the incredulity of immunologists and vaccine executives.

We check back in with Donald G. McNeil Jr. on the coronavirus and the impact of these developments.

Guest: Donald G. McNeil Jr., a science and health reporter for The New York Times

For more information on today’s episode, visit nytimes.com/thedaily

Background reading:


أكثر...

أدوات الموضوع
انواع عرض الموضوع

نون - نون ستار - نون السعودية
Powered by vBulletin® Copyright ©2000 - 2023, Jelsoft Enterprises Ltd. منتديات فوريو
adv aglitk by : aglitk